Moreover, immunoprecipitation analysis revealed that each of these RTKs formed a heterodimer with MET, demonstrating for the first time that EGFR, HER2, HER3, and RET are the main heterodimerisation partners of MET in MET amplification-positive lung cancer cells. The gene discussed is ERBB3; the disease is lung cancer.